First glaucoma review: your doctor looks for optic nerve damage, eye pressure levels, and visual field changes to assess risk and progression. It’s not just one test: careful correlation of OCT, fields, and clinical exam determines whether treatment needs to start, change, or stay stable, says Dr Shibal Bhartiya.
When I see a glaucoma patient for the first time, I am not just checking eye pressure or test reports. I am assessing whether your vision is stable, at risk, orsilently progressing over time. I also make sure we discuss any side effects you may be struggling with, especially dry eyes.
Glaucoma care is not about a single number or test. It is about understanding long-term risk and protecting vision before damage becomes obvious.
Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.
Your Treatment Should Protect Your Vision—Not Make Your Eyes Miserable
Glaucoma treatment only works if you can use it comfortably and consistently.
Many patients quietly tolerate burning, redness, watering, irritation or persistent dry eyes because they assume these are simply part of having glaucoma.
They are not always unavoidable.
During your consultation I review:
- whether your eye drops are causing ocular surface disease or dry eye
- whether preservatives may be contributing to irritation
- whether symptoms are affecting your quality of life
- whether treatment can be simplified without compromising glaucoma control
Sometimes improving comfort is just as important as lowering eye pressure because patients who are comfortable are far more likely to use their treatment consistently over many years.
Clinical Reality (What’s not always obvious)
- A single “normal” test does not rule out glaucoma—early damage can be subtle and fragmented.
- Structure and function don’t always match: OCT may look abnormal before fields change (or vice versa).
- Eye pressure alone is not enough—many patients progress at “normal” pressures.
- The first visit is a baseline, not a conclusion—true clarity often emerges only over follow-up.
- Routine eye exams can miss early glaucoma if risk and progression are not actively assessed.
What You Need To Know
| Aspect | What It Means for You |
|---|---|
| Goal of first visit | Establish baseline risk, not just confirm diagnosis |
| Key things assessed | Optic nerve, eye pressure, visual fields, OCT |
| Why multiple tests | Each test shows a different part of the disease |
| Role of history | Family history, age, systemic factors matter |
| Pressure reading | Important—but not the whole story |
| OCT scan | Detects early structural damage before symptoms |
| Visual field test | Measures functional vision loss |
| Corneal thickness | Helps interpret pressure accurately |
| Angle assessment | Determines glaucoma type and treatment path |
| Big picture | Diagnosis = pattern recognition over time, not a one-time label |
🧠 The Real Frame: Beyond Eye Pressure
Glaucoma is a neurodegenerative disease, not just an eye pressure issue.
By the time vision loss is noticeable, significant damage may already have occurred.
This is why the first consultation is less about “what is your number today” and more about:
- What has already happened
- What might happen next
- Whether your current treatment is enough
🔍 1. Is There Evidence of Progression?
The most important question is:
Is the disease stable, or changing over time?
I look at:
- Visual fields (trend, not just one report)
- OCT scans (nerve fibre layer changes)
- Disc photographs if available
A single normal test does not rule out glaucoma. Progression is often subtle and only visible when patterns are tracked over time.
🔍 2. Do Your Tests Match Your Symptoms?
Many patients say:
- “My reports are normal, but something feels off”
- “Vision feels dull, slow, or tiring”
This matters.
Early glaucoma often shows up as:
- Reduced contrast sensitivity
- Difficulty in low light
- Increased effort while reading
- Navigation discomfort
👉 This is where seeing clearly is not the same as seeing safely.
🔍 3. Is Your Eye Pressure Truly “Controlled”?
Eye pressure is important—but not sufficient.
I assess:
- Baseline pressure vs current levels
- Fluctuations (often missed)
- Target pressure relative to your nerve health
👉 A “normal” pressure may still be too high for your eye.
🔍 4. Are You Overtreated or Undertreated?
More drops do not always mean better care.
I look at:
- Number of medications
- Side effects (dryness, redness, fatigue)
- Adherence (are drops actually being used consistently?)
Sometimes:
- Too many drops → poor compliance
- Too few drops → silent progression
The goal is effective, sustainable treatment, not maximum treatment.
🔍 5. Is There a Missed Diagnosis or Overlap Condition?
Not everything labelled glaucoma behaves like glaucoma.
I actively look for:
- Optic nerve mimics
- Neuro-ophthalmic conditions
- Past misinterpretation of scans
👉 This is especially important in:
- Young patients
- Atypical progression
- “Normal pressure” cases
🔍 6. What Is Your Long-Term Risk?
This is the core of my assessment.
Not:
“How are you today?”
But:
“Where will your vision be in 5–10 years if nothing changes?”
I consider:
- Age
- Rate of progression
- Family history
- Lifestyle and follow-up patterns
👉 Glaucoma damage is often irreversible and obvious only in retrospect.
Known for her structured approach to glaucoma risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions.
🔍 7. Is Everything Being Interpreted Together?
Glaucoma is rarely diagnosed from a single report. Every investigation has strengths and limitations.
An OCT scan may appear abnormal in highly myopic eyes. A visual field may look worse simply because you were tired or distracted. Eye pressure changes throughout the day. Even optic nerves that look unusual are not always glaucomatous.
The real skill lies in bringing every piece of information together rather than relying on one number or one scan. This is why glaucoma diagnosis is often an exercise in careful clinical judgement over time rather than simply reading test reports.
⚠️ Common Misconception
Many patients believe:
“My eye pressure is normal, so my glaucoma is under control.”
or
“My OCT scan was normal, so I don’t have glaucoma.”
Unfortunately, glaucoma is rarely that simple. In reality:
Glaucoma is a disease of trend, not snapshots.
Individual test results can be misleading when viewed in isolation. The diagnosis—and equally importantly, the decision to change treatment—comes from recognising patterns over time and interpreting every finding in the context of your overall clinical picture.
Normal reports do not guarantee long-term safety.
🧭 What a First Consultation Should Give You
By the end of a proper glaucoma review, you should have clarity on:
- Whether your disease is stable or progressing
- Whether your current treatment is adequate
- What your long-term risk looks like
- What the next step should be
If these are not clear, the consultation is incomplete.
Book a Glaucoma Consultation
Whether you have recently been diagnosed with glaucoma, have been advised to start lifelong treatment, or simply want reassurance that your condition is stable, a structured glaucoma review can provide clarity.
During your consultation, Dr Shibal Bhartiya will review:
- your optic nerve examination
- OCT and visual field reports
- eye pressure and corneal thickness
- glaucoma medications and possible side effects
- dry eye symptoms and ocular surface health
- your individual risk of progression
- whether your current treatment should continue, be modified, or whether further investigations are needed
The aim is not simply to review your reports, but to help you understand your condition, your long-term risk, and the most appropriate next steps for protecting your vision.
If you have been diagnosed with glaucoma, or are unsure whether your current treatment is protecting your vision, a structured first review can help clarify your risk and next steps.
📍 Gurgaon 📞 +91 88826 38735 | 🌐 Contact Us | Second Opinion Form for teleconsults
❓ Frequently Asked Questions
Why do I need repeated tests in glaucoma?
Because glaucoma is assessed over time. One report cannot show progression or stability.
Can glaucoma be missed in routine eye exams?
Yes. Many routine exams focus on vision clarity, not optic nerve health or progression.
My eye pressure is normal. Can I still have glaucoma?
Yes. This is called normal-tension glaucoma, where damage occurs despite “normal” readings.
Do I need treatment if I have no symptoms?
Often yes. Glaucoma can progress silently before symptoms appear.
Can I reduce my medications later?
Sometimes, depending on stability, response to treatment, or after procedures like laser or surgery.
This page is a part of the Glaucoma Hub. you may want to read about Glaucoma Progression, and Risk Stratification in Glaucoma. You may want to read more about OCT and Visual Field, Glaucoma Tests Explained, Normal OCT but Vision Symptoms and How to Understand Your OCT Better. Also of help could be Why Do I Need a Visual Field Test? Glaucoma Diagnosis in Gurgaon, Get a Glaucoma Second Opinion in Gurgaon and Get an Online Glaucoma Consult.
How I Think: Every Consultation Begins With One Question
Before discussing eye drops, laser treatment or surgery, I ask one question:
“What is this patient’s lifetime risk of losing useful vision?”
Everything else follows from that answer. For some patients, careful observation is the safest approach. For others, treatment should begin immediately.
Some require more aggressive pressure lowering, while others need fewer medications because side effects are reducing adherence.
The goal is not simply to lower eye pressure—it is to preserve vision for the rest of your life using the least burdensome treatment that will safely achieve that outcome.
About the Author
This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.
She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.
As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.
1600+ Five Star Patient Reviews Google Business Profile
If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation
Read her research on PubMed | Google Scholar | ResearchGate | ORCID
📋Upload your reports for a structured review.| 🌐 Contact Us| 📞 +91 88826 38735
⭐ Helped by this article? Leave a Google review — it helps other patients find reliable eye care.